Aptium Oncology Research Network
2 clinical trials · Sponsor
◉ Watch Aptium Oncology Research Network
| Record | Firm | Date |
|---|---|---|
| Phase II Study in Patients With Operable Breast Cancer (NCT00518583) | Aptium Oncology Research Network | 2006-10-01 |
| Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC (NCT00516100) | Aptium Oncology Research Network | 2006-01-01 |
Track Aptium Oncology Research Network automatically
Every clearance here is in the API, with alerts when new ones post.